American Heart Association--Scientific Sessions 2009. Part 2.
The American Heart Association (AHA) Scientific Sessions 2009 meeting held in Orlando, FL, USA included topics covering new treatments for cardiovascular disease. This conference report highlights selected presentations on stem cell treatments for ischemia, treatments for hypertension and atherosclerosis, and LDL-lowering compounds.
Bright
Jonathan
J
Thomson Reuters, 77 Hatton Garden, London EC1N 8JS, UK. jonathan.bright@thomsonreuters.com
D000924:Anticholesteremic Agents / Q000494:pharmacology; D050197:Atherosclerosis / Q000188:drug therapy / Q000503:physiopathology; D002317:Cardiovascular Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000503:physiopathology / Q000628:therapy*; D008078:Cholesterol, LDL / Q000097:blood / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000503:physiopathology; D017202:Myocardial Ischemia / Q000628:therapy; D033581:Stem Cell Transplantation / Q000379:methods
D000924:Anticholesteremic Agents; D002317:Cardiovascular Agents; D008078:Cholesterol, LDL